The organizations have agreed to collaborate over the next two years to develop the world’s first dedicated pediatric magnetoencephalography (MEG) functional brain imaging system. The pediatric system development
Organon will be responsible for the marketing, sales, and managed markets activities including pricing and contracting as well as recording sales for Anzemet Injection. The company will promote
NX-1207 is Nymox’s lead drug candidate for the treatment of benign prostatic hyperplasia (BPH). The company believes the drug shows good promise as a potential first-line treatment for
In the study measuring user satisfaction, 58-70% of patient and 65-75% of partners preferred the Cialis to Viagra after they had switched from either Viagra to Cialis or
Results from a clinical trial conducted to support the Hylenex NDA demonstrated no allergic reactions and significantly reduced injection site discomfort. The data showed injection site discomfort (e.g.,
The data safety monitoring board (DSMB) made its recommendation in a meeting with the company, the purpose of which was to review available data once 1,500 enrolled infants
In the study, one of three pivotal studies of the drug, Sparlon significantly improved the symptoms associated with ADHD as reported by physicians, parents and teachers, and was
The appeal was made after a number of group medical practices and private clinics were found to have administered unregistered flu vaccines to members of the public. A
The two companies have been co-developing a tablet-form oral insulin, IN1O5, for both type 1 and type 2 diabetes since announcing a tie-up in October 2004. This drug
During an “end-of-phase II meeting”, the FDA agreed that a single well-controlled study would be sufficient to support licensure of NOV-002 for the first-line treatment of chemotherapy-naïve, advanced
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.